BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28156153)

  • 1. SHOULD MULTIFOCAL PAPILLARY THYROID CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B?
    Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B
    Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
    Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
    Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
    Elbasan O; Ilgın C; Gogas Yavuz D
    Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
    Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
    J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis.
    Liu C; Wang S; Zeng W; Guo Y; Liu Z; Huang T
    Sci Rep; 2017 May; 7(1):1846. PubMed ID: 28500312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.
    Zhao Q; Ming J; Liu C; Shi L; Xu X; Nie X; Huang T
    Ann Surg Oncol; 2013 Mar; 20(3):746-52. PubMed ID: 22972508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
    Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
    Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
    Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
    JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total surface area is useful for differentiating between aggressive and favorable multifocal papillary thyroid carcinomas.
    Pyo JS; Sohn JH; Kang G; Kim DH; Yun J
    Yonsei Med J; 2015 Mar; 56(2):355-61. PubMed ID: 25683981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can ratio of the biggest tumor diameter to total tumor diameter be a new parameter in the differential diagnosis of agressive and favorable multifocal papillary thyroid microcarcinoma?
    Tam AA; Özdemir D; Çuhacı N; Başer H; Dirikoç A; Aydın C; Yazgan AK; Ersoy R; Çakır B
    Oral Oncol; 2017 Feb; 65():1-7. PubMed ID: 28109462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Multifocal Papillary Thyroid Microcarcinoma With a Total Tumor Diameter >1 cm Indicate Poor Biological Behavior? The Evidence is Insufficient.
    Zhou B; Wei L; Qin J
    Endocr Pract; 2021 Feb; 27(2):131-136. PubMed ID: 33547013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
    Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
    World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary thyroid microcarcinomas that metastasize to lymph nodes.
    Dirikoc A; Tam AA; Ince N; Ozdemir D; Topaloglu O; Alkan A; Yazgan AK; Ersoy R; Cakir B
    Am J Otolaryngol; 2021; 42(5):103023. PubMed ID: 33838358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.
    Jiang KC; Lin B; Zhang Y; Zhao LQ; Luo DC
    Front Endocrinol (Lausanne); 2022; 13():974755. PubMed ID: 36004348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients.
    Yin X; Liu C; Guo Y; Li X; Shen N; Zhao X; Yu P; Wang S; Liu Z
    World J Surg Oncol; 2017 Jul; 15(1):133. PubMed ID: 28716127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor border pattern and size help predict lymph node status in papillary microcarcinoma: A clinicopathologic study.
    Taşkın OÇ; Armutlu A; Ağcaoğlu O; Peker Ö; Terzioğlu T; Demirkol MO; Tezelman S; Kapran Y
    Ann Diagn Pathol; 2020 Oct; 48():151592. PubMed ID: 32871504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.
    Zhao L; Sun X; Luo Y; Wang F; Lyu Z
    Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
    Anderson KL; Youngwirth LM; Scheri RP; Stang MT; Roman SA; Sosa JA
    Thyroid; 2016 Aug; 26(8):1046-52. PubMed ID: 27266722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
    Kim WY; Kim HY; Son GS; Bae JW; Lee JB
    J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.